Treatment with PIM1 inhibitors SGI-1776 and TP-3654 affected proliferation and apoptosis in PAH-PASMCs in an anti-pathological manner (Figure 3) [67]. This evidence concerns the gene PIM1 and pulmonary arterial hypertension.